$9.72
0.101.04%
After Hours: 9:30 AM EDT
Corbus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Corbus Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-1.15 | $-0.95 | -21.1 % |
Q2 | 2024-08-06 | $-0.90 | $-1.26 | 28.6 % |
Q1 | 2024-05-07 | $-0.83 | $-1.52 | 45.4 % |
Q4 | 2024-03-12 | $-1.81 | $-2.36 | 23.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q2 | 2022-08-09 | $0 | $100.00K | -100.0 % |
Q1 | 2022-05-10 | $0 | $150.00K | -100.0 % |
Q4 | 2022-03-08 | $0 | $350.00K | -100.0 % |
Q3 | 2021-11-12 | $97.32K | $650.00K | -85.0 % |
Corbus Pharmaceuticals (CRBP) is scheduled to report earnings on March 11, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-1.15, which missed the estimate of $-0.95.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.